NAD+ Testing: How to Measure Your Levels and What They Mean for Aging

You've probably heard that NAD+ declines with age and that increasing it might slow aging (NAD+ in aging: molecular mechanisms and translational implications) (safety and anti-aging effects of NMN in clinical trials). But before you reach for a supplement or sign up for an IV drip, there's a more fundamental question: can you actually measure your NAD+ levels in a way that tells you something useful? The answer is more complicated than the wellness industry suggests (chronic NR supplementation elevates NAD+ in healthy adults). Most available tests measure NAD+ in blood, which doesn't reflect what's happening inside your cells where the molecule actually does its work. Understanding what NAD+ testing can and can't tell you is the first step toward making informed decisions about your cellular health.

Key Takeaways

• Intracellular NAD+ is difficult to measure accurately in clinical settings.
• Blood NAD+ levels don't reliably reflect what's happening inside your cells.
• NAD+ decline with age impairs energy production and DNA repair capacity (NAD+ metabolism after long-term NMN supplementation (RCT)).
• Most commercial NAD+ tests use dried blood spot samples, not tissue biopsies.
• High-performance liquid chromatography is the gold standard for NAD+ measurement.
• NAD+ connects to multiple hallmarks of aging, including mitochondrial dysfunction.
• Human evidence for NAD+ precursor supplementation remains limited despite animal data (NMN and NR as NAD+ precursors and their health contribution).

What NAD+ Actually Does at the Cellular Level

NAD+ functions as an electron carrier in cellular energy production and serves as a substrate for enzymes that regulate DNA repair, gene expression, and cellular stress responses. Every time a mitochondrion converts glucose or fat into ATP, NAD+ accepts electrons and becomes NADH. That NADH then delivers those electrons down the respiratory chain, regenerating NAD+ in the process.

Beyond energy metabolism, NAD+ is consumed by poly(ADP-ribose) polymerases (PARPs), enzymes that detect and repair DNA damage by adding ADP-ribose chains to proteins at damage sites. When DNA damage accumulates faster than it can be repaired, as happens with aging or environmental stress, PARPs consume NAD+ at an accelerated rate. This creates a metabolic trade-off: the more your cells invest in DNA repair, the less NAD+ remains available for energy production and other essential processes.

Sirtuins, another class of NAD+-consuming enzymes, remove acetyl groups from histones and other proteins to regulate gene expression, mitochondrial function, and cellular stress resistance. This decline isn't uniform across cell types or subcellular compartments. Cytoplasmic NAD+ may be around 70 micromolar in cultured cells, while nuclear NAD+ runs closer to 110 micromolar. These compartment-specific pools don't equilibrate freely, which means measuring total cellular NAD+ may miss important shifts in where the molecule is concentrated and how it's being used.

How NAD+ Decline Connects to the Hallmarks of Aging

NAD+ depletion impairs mitochondrial quality control by reducing the activity of SIRT1 and SIRT3, sirtuins that regulate mitochondrial biogenesis and the removal of damaged mitochondria. Damaged mitochondria that would normally be cleared through mitophagy, an NAD+-dependent process, accumulate instead.

Cellular senescence, the irreversible growth arrest that accumulates with age, is both a cause and consequence of NAD+ decline. Senescent cells themselves have altered NAD+ metabolism, often showing reduced NAD+ biosynthesis and increased consumption by stress-response enzymes. This means senescence both results from and contributes to NAD+ depletion.

Genomic instability accelerates when NAD+ levels fall below the threshold needed for efficient DNA repair. PARP activation in response to DNA breaks consumes NAD+ rapidly, and chronic PARP activity, as seen with persistent low-level DNA damage in aging, can deplete cellular NAD+ pools to the point where energy metabolism and other NAD+-dependent processes are compromised.

What Drives NAD+ Levels Up or Down

Age-related decline in biosynthesis capacity

The primary driver of NAD+ decline with age is reduced expression and activity of nicotinamide phosphoribosyltransferase (NAMPT), the rate-limiting enzyme in the salvage pathway that recycles nicotinamide back into NAD+. This means older cells are less efficient at regenerating NAD+ from the nicotinamide released when sirtuins and PARPs consume it.

Metabolic state and physical activity

Caloric restriction and fasting increase NAD+ levels by upregulating NAMPT expression and reducing NAD+ consumption. When nutrient availability is low, cells shift toward catabolic metabolism, which generates rather than consumes NAD+. Exercise, particularly aerobic exercise, stimulates mitochondrial biogenesis through PGC-1alpha activation, a process that requires and helps maintain NAD+ pools. Resistance training may have less direct effects on NAD+ but improves insulin sensitivity, which indirectly supports NAD+ metabolism by reducing chronic metabolic stress.

Dietary factors and substance use

Dietary intake of NAD+ precursors matters, though less than you might expect. Nicotinamide, nicotinic acid, and tryptophan all feed into NAD+ biosynthesis pathways. However, the salvage pathway's efficiency means that simply increasing precursor availability doesn't necessarily translate to higher intracellular NAD+ unless biosynthesis capacity is the limiting factor. Alcohol consumption impairs NAD+ metabolism by shifting the NAD+/NADH ratio toward NADH, which can inhibit key metabolic enzymes and reduce cellular energy production.

Why Individual NAD+ Levels Vary So Much

Genetic variation in NAD+ biosynthesis and consumption enzymes creates substantial individual differences in baseline NAD+ levels and the rate of age-related decline. Polymorphisms in NAMPT, the rate-limiting enzyme in the salvage pathway, affect how efficiently cells recycle nicotinamide into NAD+. Variants in sirtuin genes influence how rapidly NAD+ is consumed for epigenetic regulation and stress response.

Metabolic phenotype plays a major role. Individuals with insulin resistance show accelerated NAD+ decline, likely due to increased oxidative stress and inflammation. Mitochondrial efficiency varies substantially between people, affecting both NAD+ production through oxidative phosphorylation and NAD+ consumption through mitochondrial sirtuins. Those with naturally higher mitochondrial density and function tend to maintain NAD+ levels better with age.

Chronic inflammatory conditions, autoimmune diseases, and persistent infections all increase NAD+ consumption through PARP activation and immune cell metabolism. Environmental exposures to toxins, pollutants, and radiation cause DNA damage that triggers PARP-mediated NAD+ depletion. Sleep deprivation disrupts circadian regulation of NAD+ biosynthesis enzymes, leading to lower baseline levels and impaired recovery from metabolic stress.

Hormonal status influences NAD+ metabolism, particularly during major transitions. Menopause is associated with declining NAD+ levels, likely mediated by loss of estrogen's protective effects on mitochondrial function and increased inflammatory signaling. Growth hormone and IGF-1 levels, which decline with age, affect NAD+ biosynthesis through effects on cellular metabolism and stress resistance. Thyroid function directly impacts NAD+ turnover, as thyroid hormones regulate mitochondrial biogenesis and metabolic rate.

What the Evidence Actually Shows About NAD+ Testing and Supplementation

The measurement challenge

The gold standard for NAD+ measurement is high-performance liquid chromatography (HPLC) or mass spectrometry performed on fresh tissue samples. This method accurately quantifies NAD+, NADH, and related metabolites in specific tissues. The problem is that it requires tissue biopsies, making it impractical for routine clinical use. Most commercial NAD+ tests instead use dried blood spot samples, measuring whole blood NAD+ levels.

Blood NAD+ doesn't correlate well with intracellular NAD+ in metabolically active tissues like muscle, liver, or brain. NAD+ doesn't cross cell membranes freely, and blood cells have different metabolic demands than other tissues. This means a blood test might tell you something about NAD+ metabolism in blood cells, but it won't tell you whether your muscle cells have sufficient NAD+ for optimal mitochondrial function or whether your neurons have enough NAD+ for DNA repair.

Animal versus human data

Animal studies consistently show that supplementation with NAD+ precursors like nicotinamide riboside (NR) or nicotinamide mononucleotide (NMN) increases tissue NAD+ levels and improves markers of metabolic health, mitochondrial function, and lifespan in rodents. Human trials are more mixed. Some studies show that oral NR or NMN supplementation increases blood NAD+ levels and improves insulin sensitivity or exercise capacity in specific populations. Others find no significant effects on tissue NAD+ or functional outcomes.

The disconnect between animal and human data likely reflects several factors:

• Mice have much higher metabolic rates than humans, meaning their NAD+ turnover is faster and potentially more responsive to precursor supplementation.
• Most human trials have been short-term, lasting weeks to months rather than years, which may not be long enough to detect effects on aging-related outcomes.
• The doses used in mouse studies, when adjusted for body weight, often exceed what's practical or safe in humans.
• Genetic and metabolic heterogeneity in human populations may mean that only certain individuals respond to NAD+ precursor supplementation.

Measuring What Actually Matters for Your Cellular Health

If direct intracellular NAD+ testing isn't practical, what biomarkers give you meaningful information about NAD+-related metabolic health? Fructosamine reflects average blood glucose over the past two to three weeks, complementing HbA1c and providing insight into glycemic control, which directly affects NAD+/NADH ratios. Fasting insulin and HOMA-IR measure insulin sensitivity, a key determinant of metabolic stress and NAD+ consumption.

Markers of mitochondrial function provide indirect but relevant information. Lactate levels during exercise testing reflect the efficiency of oxidative phosphorylation, which depends on adequate NAD+ availability. High-sensitivity CRP measures systemic inflammation, which accelerates NAD+ depletion through PARP activation and oxidative stress. Ferritin, when elevated in the absence of iron deficiency, can indicate inflammation and oxidative stress that impact NAD+ metabolism.

Homocysteine levels reflect methylation capacity and B-vitamin status, both of which intersect with NAD+ metabolism through one-carbon metabolism pathways. Vitamin B12 and folate are cofactors in pathways that support NAD+ biosynthesis. Uric acid provides information about purine metabolism and oxidative stress, both relevant to cellular energy status.

Body composition matters more than weight alone. DEXA-derived lean mass and visceral fat area correlate with metabolic health and NAD+ status. Muscle mass is both a major site of NAD+ metabolism and a determinant of metabolic resilience. Visceral adiposity drives inflammation and insulin resistance, both of which accelerate NAD+ decline. Tracking these markers over time gives you a trajectory, not just a snapshot, which is more informative for understanding how your metabolism is aging.

Putting NAD+ Science Into Practice

Understanding your NAD+-related metabolic health requires looking at the full metabolic picture, not just a single NAD+ measurement. Superpower's 100+ biomarker panel covers the metabolic, inflammatory, and hormonal markers that determine how efficiently your cells produce and use NAD+. Tracking fasting glucose, insulin, hsCRP, and homocysteine alongside body composition and functional capacity gives you actionable data on the inputs that drive NAD+ metabolism, even when direct intracellular NAD+ testing isn't available.